Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Formulation (FDF)
Terlipressin Injection
Injection · 0.1mg/ml(8.5ml)
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB471)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- EU
Formulation (FDF)
Pantoprazole Injection
Injection · 40mg
- Therapy
- Gastroenterology & Hepatology
- Status
- Official FDF licensing catalog (UB470)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- EU, Singapore
Formulation (FDF)
Topiramate SR Capsules
Capsules · 200mg; 100mg; 25mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB469)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Brivaracetam Injection
Injection · 50mg/5ml
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB468)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Brivaracetam Oral Solution
Oral Solution · 10mg/ml
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB467)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Brivaracetam Tablet
Tablet · 25mg; 50mg; 75mg; 100mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB466)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Levetiracetam Injection
Injection · 500mg/5ml
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB465)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, EU
Formulation (FDF)
Lacosamide Injection
Injection · 200mg/20ml
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB464)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Oxcarbazepine Tablet
Tablet · 150mg, 300mg,600mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB463)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- EU
Formulation (FDF)
Levofloxacin Tablet
Tablet · 250mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB462)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- EU
Formulation (FDF)
Lincomycin Injection
Injection · 600mg/2ml, 3g/10ml
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB461)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Tobramycin Sulfate Injection
Injection · 1.2g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB460)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Daptomycin for Injection
for Injection · 350mg,500mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB459)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, EU
Formulation (FDF)
Vancomycin Injection
Injection · 500mg, 1g, 5g, 10g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB458)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, EU
Formulation (FDF)
Azithromycin Oral Suspension
Suspension · 100mg/5mL: 15mL 200mg/5mL: 15mL, 22.5mL, 30mL
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB457)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Azithromycin Injection
Injection · 500mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB456)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, EU
Formulation (FDF)
Teicoplanin Injection
Injection · 200mg, 400mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB455)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Posaconazole Injection
Injection · 300mg/16.7ml
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB454)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tigecycline Injection
Injection · 50mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB453)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- EU
Formulation (FDF)
Fluconazole Oral Suspension
Suspension · 200mg/5ml,35m
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB452)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Doxycycline Injection
Injection · 100 mg, 200 mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB451)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Voriconazole Injection
Injection · 200mg/20m
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB450)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- EU
Formulation (FDF)
Voriconazole Injection
Injection · 200mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB449)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, EU
Formulation (FDF)
Voriconazole Oral Suspension
Suspension · 200mg/5ml,75ml
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB448)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Oseltamivir Capsule
Capsule · 75mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB447)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Acyclovir Injection
Injection · 500mg/10ml
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB446)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Ganciclovir Injection
Injection · 500mg
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB445)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, EU, WHO
Formulation (FDF)
Gadoteridol Injection
Injection · 0.5mmol/ml: 5ml, 10ml, 15ml, 20ml
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Official FDF licensing catalog (UB444)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Gadoterate Meglumine Injection
Injection · 0.5mmol/ml: 5mL, 10mL, 15mL, 20mL, 100mL
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Official FDF licensing catalog (UB443)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Gadobutrol Injection
Injection · 1mmol/ml: 2ml, 7.5ml, 10ml, 15ml, 30ml, 65ml
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Official FDF licensing catalog (UB442)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Iopamidol Injection
Injection · 200mg(I)/ml (41%): 10ml, 20ml, 50ml 250mg(I)/ml (51%): 50ml 300mg(I)/ml (61%): 15ml, 30ml, 50ml 370mg(I)/ml (76%): 50ml, 75ml, 100ml
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Official FDF licensing catalog (UB441)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
HIV Test Kit
—
- Therapy
- Others > Medical Devices & Diagnostics
- Status
- Official FDF licensing catalog (UB440)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Mifanertinib Maleate Tablets
Tablets · 40mg; 80mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB420)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lidocaine Hydrochloride Gel (2%)
Gel · 2%
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB419)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- To be assessed
Formulation (FDF)
Pelubiprofen CR Tablet (Controlled Release)
Tablet · 45mg, twice daily
- Therapy
- Others > Rheumatology
- Status
- Official FDF licensing catalog (UB417)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- South Korea
Formulation (FDF)
Hydrocortisone Sodium Succinate injection
injection · 50mg/100mg
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB359)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Methylprednisolone Sodium Succinate for Injection
for Injection · 40mg; 125mg; 500mg; 1g; 2g
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB358)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Dexamethasone Sodium Phosphate injection
injection · 4mg/ml
- Therapy
- Immunology & Inflammation
- Status
- Official FDF licensing catalog (UB357)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Tazovid (a combination pack of atelovir tablets and ritonavir tablets)
tablets · 0.15g/0.1g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB346)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ceftazidime and Avibactam Sodium for Injection
for Injection · 2.0g/0.5g
- Therapy
- Infectious Diseases
- Status
- Official FDF licensing catalog (UB334)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
small molecule - 37
—
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB311)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Sorafenib Tosylate Tablets
Tablets · 0.2g
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB308)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Letrozole Tablets
Tablets · 2.5mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB307)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Anastrozole Tablets
Tablets · 1mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB306)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Decitabine for Injection
for Injection · 25mg; 50mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB305)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Adenosine Injection
Injection · 2ml: 6mg; 20ml: 60mg; 30ml: 90mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB304)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Indobufen Tablets
Tablets · 100mg; 200mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB303)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ustekinumab Injection
Injection · 0.5ml: 45mg
- Therapy
- Others > Dermatology
- Status
- Official FDF licensing catalog (UB301)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China